C.R. Bard Pays $21 Million to Settle Transvaginal Mesh Suits
C.R. Bard Inc. agreed over the summer to a $21 million transvaginal mesh settlement that made them the second manufacturer to recently resolve claims filed by women who allege pain, infection and other serious injuries, according to Bloomberg Businessweek.
A report on October 8th describes the details of a settlement that may cancel out at least 500 lawsuits over pelvic implants that include those part of its Avaulta line. A spokesperson for Bard said the agreement was actually announced in July, and is “already out there,” despite the buzz that surfaced this week. The news was contained in a July 24th filing with the U.S. Securities and Exchange Commission, which noted charges totaling $262.7 million in costs associated with product liability lawsuits. $4.2 million in defense costs needed to prepare 200 individual cases for trial were also included.
West Virginia Judge Asks Bard to Prep for 500 Transvaginal Mesh Trials
According to Bloomberg, the deal follows an order from a federal judge in the U.S. District Court, Southern District of West Virginia that the company start preparing for trials of 500 lawsuits alleging organ damage that resulted in complications such as constant pain, pain during sexual intercourse and scarring.
Bard is not the only transvaginal mesh manufacturer to make efforts in stifling future litigation. On September 30, the parent company to American Medical Systems announced that an additional $400 million would be added to its reserve for mesh-related claims, which now includes $1.6 billion. The settlement would resolve approximately 20,000 lawsuits over its Apogee, Perigee and Elevate implants for an estimated $48,000 each, Bloomberg stated at the time.
In Bard’s case, parties close to the agreement confirmed that its terms were similar, in that plaintiffs may receive more than $43,000 per vaginal mesh lawsuit.
Cases involving C.R. Bard and American Medical Systems are continuing to increase in the Southern District of West Virginia, and are moving forward at a steady pace. A Case List updated on September 15th shows 9,745 federal claims now pending in the federal litigation involving C.R. Bard lawsuits and more than 18,700 filed in a separate proceeding established for American Medical Systems cases.
All of these lawsuits follow multiple warnings from the U.S. Food and Drug Administration (FDA), including one in 2011 that categorized the risk for mesh erosion and other complications as “not rare.”
Consider a Transvaginal Mesh Lawsuit
File a transvaginal mesh lawsuit with an attorney at Bernstein Liebhard LLP today: (877) 779-1414.